CORNERSTONE FIN (08112) announced its interim results, reporting a loss attributable to shareholders of HKD 10.0455 million, a year-on-year decrease of 52.89%.
Cornerstone Financial (08112) announced its interim results for the six months ended June 30, 2026, with the group achieving revenue of HKD 15.5358 million, a decrease of 42.03% year-on-year; the loss attributable to owners of the company was HKD 10.0455 million, a decrease of 52.89% year-on-year; the loss per share was HKD 0.0438.
CORNERSTONE FIN (08112) announced its interim results for the six months ended June 30, 2026, reporting revenue of HKD 15.5358 million, a decrease of 42.03% year-on-year; loss attributable to owners of the company was HKD 10.0455 million, a decrease of 52.89% year-on-year; loss per share was HKD 0.0438.
Related Articles
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."
Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.
Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."
Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.
Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
RECOMMEND
